A myocardial infarction may disclose patent foramen ovale  by Trabattoni, Daniela et al.
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KEYWORDS Summary  We  report  a  case  of  a  19-year-old  man  presenting  with  an  acute  myocardial  infarc-
tion. Coronary  arteries  were  free  from  atherosclerotic  disease.  A  patent  foramen  ovale  (PFO)Patent  foramen
ovale;
Coronary
embolization;
Acute  myocardial
infarction
was detected  on  contrast  echocardiography  with  right-to-left  shunting  during  Valsalva  maneu-
ver. No  other  embolic  source  was  identiﬁed.  We  closed  the  patient’s  PFO  with  a  23-mm  PFO
occluder. No  residual  intracardiac  shunt  was  found  on  contrast  transthoracic  echocardiography
at 1-year  follow-up  and  no  recurrent  paradoxical  embolization  occurred.
© 2012  Published  by  Elsevier  Ltd  on  behalf  of  Japanese  College  of  Cardiology.
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ercutaneous  closure  of  patent  foramen  ovale  (PFO)  after
ryptogenic  stroke  is  increasingly  considered  as  a  thera-
eutic  option.  However,  American  Heart  Association  and
merican  Stroke  Association  guidelines  for  PFO  closure
o  not  take  into  account  other  non-cerebral  embolic
vents.
A  19-year-old  man  with  a  negative  clinical  history,
as  admitted  to  the  emergency  room  during  the  night
or  acute  chest  pain  onset  while  he  was  playing  foot-
all.  The  electrocardiogram  showed  7-mm  ST-elevation
n  V2—V6  and  d1-aVl  leads.  Coronary  angiogram  showed
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oi:10.1016/j.jccase.2011.08.007vidence  of  a  huge  thrombus  burden  at  proximal  left
nterior  descending  artery  (LAD)  with  distal  thrombotic
mbolization  (Fig.  1a,  top).  Creatine  kinase-MB  peak  value
eached  233  ng/ml.  A  strategy  based  on  LAD  thrombus
emoval  via  a  5F  Export  aspiration  catheter  (Medtronic  Vas-
ular,  Santa  Rosa,  CA,  USA)  and  three  direct  bare-metal
verlapped  stents  (Driver  4.0  ×  30  mm;  Driver  3.5  ×  30  mm;
river  3.5  ×  30  mm;  Medtronic  Inc.,  Minneapolis,  MN,  USA)
mplantation,  was  adopted  (Fig.  1b),  in  the  doubt  of  a  trau-
atic/spontaneous  coronary  dissection  causing  the  acute
vent.  However,  intravascular  ultrasound  images,  obtained
efore  stenting,  showed  fresh  thrombus  in  the  lumen  vessel
ut  no  dissections  nor  atherosclerotic  lesions  (Fig.  1a,  bot-
om).  A  pre-discharge  transthoracic  echocardiograph  was
erformed  showing  good  left  ventricular  function  (ejection
raction  =  55%)  and  atrial  septum  bulging  with  a  right-to-
eft  shunt  during  Valsalva  maneuver.  A  ‘‘shower  pattern’’
ight-to-left  shunt  was  detected  on  a  contrast  transcranial
oppler  while  thrombophilic  screening  tests  were  negative.
alf of Japanese College of Cardiology.
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Figure  1  (a)  (top)  acute  LAD  occlusion  and  electrocardiogram  at  presentation;  (bottom)  intravascular  ultrasound  image  showing
thrombus adherence  to  the  intracoronary  catheter.  (b)  LAD  post  primary  percutaneous  coronary  intervention  and  electrocardiogram
Eat discharge.  LAD,  left  anterior  descending  artery.
Brain  magnetic  resonance  imaging  (MRI)  was  normal.  The
patient  was  discharged  on  aspirin  and  clopidogrel  and  per-
cutaneous  PFO  closure  was  electively  scheduled  six  months
later.  The  procedure  was  performed  under  local  anesthesia;
an  intracardiac  ultrasound  guidance  (9F,  9-MHz  Ultra  ICE;
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Figure  2  (a)  Patent  foramen  ovale  (PFO)  at  intracardiac  echocar
image. LA,  left  atrium;  RA,  right  atrium.P  Technologies,  Boston  Scientiﬁc  Corporation,  San  Jose,
A,  USA)  was  adopted  and  a  23-mm  BioSTAR  (NMT  Medical,
oston,  MA,  USA)  device  was  successfully  implanted  (Fig.  2a
nd  b).  Coronary  angiogram  performed  immediately  before
FO  closure  showed  stent  patency  without  neointimal
diogram  (ICE)  evaluation.  (b)  ICE  post  PFO  closure  and  device
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yperplasia.  During  1-year  follow-up  no  complications
ccurred  and  no  residual  shunt  was  diagnosed  on  contrast-
ransthoracic  echocardiography.
iscussion
aradoxical  embolism  in  PFO  patients  may  translate  into
ubclinical  or  clinical  cerebral  ischemic  events,  but  may  also
each  other  vascular  beds  and  in  case  of  coronary  arteries,
ause  an  acute  myocardial  infarction  (MI).
The  evidence  of  a  thrombus  in  a  PFO  has  been  docu-
ented  [1].  In  most  cases  no  thrombus  is  detectable  both
t  trans-esophageal  echocardiography  and  at  intracardiac
chocardiographic  evaluation  in  PFO  patients.  However,  a
ecent  study  by  Wohrle  et  al.  [2]  demonstrated  subclinical  MI
n  10.8%  of  patients  with  PFO  undergoing  cardiac  MRI  after
 ﬁrst  cryptogenic  cerebral  ischemic  event.  The  trend  for
 larger  PFO  size  in  patients  with  myocardial  scar  detec-
ion  at  MRI  may  be  a  marker  for  a  second  event  allowing
or  an  easier  passage  of  paradoxical  emboli  or  of  a  larger
lot  with  subsequent  fragmentation.  This  study  strength-
ns  the  pathophysiologic  role  of  a  PFO  with  paradoxical
mbolism.  In  our  case  the  presumptive  extracerebral  para-
oxical  embolism  was  associated  with  the  acute  anterior
I  occurrence  as  fresh  thrombus,  no  coronary  stenosis,  and
he  absence  of  genetic  or  acquired  prothrombotic  disorders,
[D.  Trabattoni  et  al.
fter  excluding  all  other  possible  causes,  were  observed.
rump  et  al.  [3]  evaluated  the  incidence  of  PFO  in  patients
ith  acute  MI  and  angiographically  normal  coronary  arteries.
he  prevalence  of  PFO  they  found  in  these  patients  was  sim-
lar  to  that  observed  in  the  control  group  without  any  history
f  coronary  disease.  This  suggests  that  paradoxical  embolism
hrough  a  PFO  is  a  rare  and  uncommon  cause  of  acute  MI  with
ormal  coronary  arteries.  This  observation  together  with
ew  previous  clinical  reports  opens  new  horizons  in  the  clin-
cal  evaluation  of  young  patients  presenting  with  an  acute
oronary  syndrome  without  substantial  evidence  of  coronary
isease.
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